Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,925 | -5,480 | N/A | N/A | N/A |
| Depreciation Amortization | 76 | 60 | N/A | N/A | N/A |
| Other Working Capital | -251 | 253 | N/A | N/A | N/A |
| Other Operating Activity | 244 | 773 | 0 | 0 | 0 |
| Operating Cash Flow | $-4,857 | $-4,395 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33 | -162 | N/A | N/A | N/A |
| Investing Cash Flow | $-33 | $-162 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 952 | 7,548 | N/A | N/A | N/A |
| Other Financing Activity | -36 | -128 | 0 | 0 | 0 |
| Financing Cash Flow | $916 | $7,420 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 5,293 | 2,429 | N/A | N/A | N/A |
| End Cash Position | 1,318 | 5,293 | N/A | N/A | N/A |
| Net Cash Flow | $-3,975 | $2,864 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,857 | -4,395 | N/A | N/A | N/A |
| Capital Expenditure | -33 | -162 | N/A | N/A | N/A |
| Free Cash Flow | -4,890 | -4,557 | 0 | 0 | 0 |